Clinical Trial Update: In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing predictive models for recurrence and progression in non-muscle invasive bladder cancer, comparing EORTC and CUETO scoring systems; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Snippet

Sponsor: Ankara Training and Research Hospital | Conditions: Bladder Cancer, Disease Progression | Phase 4 | Status: COMPLETED